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A B S T RA C T Crosslinked fibrin was digested by
plasmin, and three soluble complexes larger than
DD/E were purified and characterized. After gel filtra-
tion chromatography, the purified complexes were
shown to have molecular weights of 465,000, 703,000,
and 850,000, as determined by equilibrium sedimenta-
tion. Each of the complexes was dissociated into two or
more fragments by SDS-polyacrylamide gel electro-
phoresis. The structure of these subunit fragments was
deduced from determinations of their molecular
weights and polypeptide chain composition and from
known sites of plasmin cleavage of fibrin. Fragments
larger than DD have been identified that contain
intact yry crosslinks as well as fragments resulting from
cleavages at or near this site. The former include DY
(mol wt 247,000), YY (mol wt 285,000), DXD(mol wt
461,000), and YXD (mol wt 500,000); and the latter
include fragments XD(mol wt 334,000) and XY (mol wt
391,000). A schematic model was developed to explain
the structure of the large noncovalently bound com-
plexes based on their molecular weight and observed
component fragments. Our scheme supports the two-
stranded half-staggered overlap model as the basic
unit of fibrin structure, in which each complex con-
sists of fragments from two adjacent complementary
antiparallel fibrin strands. The smallest derivative,
complex 1, is the DD/E complex; complex 2 contains
apposed DYand YD fragments, and complex 3 consists
of fragments DXD and YY. Complex 4 is less well-
characterized, but its intact structure is projected to
consist of YXD and DXY fragments from adjacent
fibrin strands. Each complex is heterogeneous in sub-
unit composition, reflecting additional plasmin cleav-
ages within and/or adjacent to its theoretical boundaries.
Since most of the protein initially released into solution
from degrading fibrin is as complexes larger than DD/E,
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the derivatives described in this report are likely to be
major circulating degradation products of crosslinked
fibrin in vivo.
INTRODUCTION
Plasmic degradation of fibrinogen and noncrosslinked
fibrin produces transient intermediate fragments X
and Y (1, 2) and the principal terminal fragments D
and E (3, 4). Crosslinked fibrin contains Factor XIIIa-
induced isopeptide bonds betveen y chains of adjacent
monomer pairs that result in major differences of the
structure of proteolytic derivatives. The yy crosslink
is relatively resistant to plasmin action (5), and ex-
tensive degradation of crosslinked fibrin therefore
results in the covalently bound dimer, fragment DD
(6-8), fragment D, and a noncovalently bound com-
plex of DDand E (9, 10). Studies of less extensively
degraded crosslinked fibrin digests by sodium dodecyl
sulfate (SDS)-polyacrylamide gel electrophoresis (11,
12) have identified several derivatives larger than
fragment DD, although their molecular weights have
not been determined, and possible arrangements into
complexes in physiologic conditions have not been
considered. Gaffney and Joe (13) have suggested that
the DD/E complex may aggregate to form high molecu-
lar weight species, but they offered no data to support
this hypothesis. Francis et al. (14) have shown that most
of the protein initially released into solution from fibrin
by plasmic digestion is in noncovalently bound com-
plexes that are larger than DD/E (14). We have now
separated and purified three distinct soluble complexes
that are much larger than DD/E. Their molecular
weights have been determined by gel elution and by
equilibrium sedimentation analysis. The fragments
that are dissociated from the complexes by SDS-
polyacrylamide gel electrophoresis have been charac-
terized by molecular weight measurements and poly-
peptide chain analyses. Using these data,, we have
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formulated a structure for the macromolecular com-
plexes that is consistent with the half-overlap, two-
stranded linear fibrin structural model (15-18). Since
these derivatives may be protected from degradation
in the circulation by proteolytic inhibitors, our results
are critical to the development and interpretation of
assays to detect circulating degradation products of
crosslinked fibrin, whether based upon their size
(19-22) or antigenic determinants (23, 24).
METHODS
Human fibrinogen (grade L) was purchased from KABI (AB)
(Stockholm). Human thrombin (U. S. standard thrombin, lot
HI) and plasmin were kindly supplied by Dr. David Aronson
(Bureau of Biologics Standards, Bethesda, Md.). Acrylamide
was obtained from Eastman Kodak Co. (Rochester, N. Y.)
and recrystallized from a saturated solution of chloroform.
Sodium dodecyl sulfate was purchased from Sigma Chemical
Co. (St. Louis, Mo.) and recrystallized from ethanol. Phos-
phorylase A (from rabbit muscle), soybean trypsin inhibitor
(type 1-5), carboxypeptidase A (type II), myoglobin (type
1), bovine serum albumin (fraction V), chymotrypsinogen A
(type II), and P-galactosidase (grade IV) were obtained from
Sigma Chemical Co. Chromatographically purified human
IgM and IgG were purchased from N. L. Cappel Labora-
tories Inc., Cochranville, Pa. Aldolase, catalase, ferritin, and
thyroglobulin were obtained from Pharmacia Fine Chemicals
(Div. of Pharmacia, Inc. (Piscataway, N. J.). Epsilon-amino-
caproic acid was obtained from Sigma Chemical Co. and
aprotinin (Trasylol) from Mobay Chemical Corp. (New York).
Crosslinked fibrin was prepared and plasmic degradation of
crosslinked fibrin performed as previously described (22).
A 50-mg portion of ground fibrin was suspended in 2.0 ml
of 0.15 M sodium chloride, 0.05 N4 Tris-hydrochloric acid
buffer, pH 7.6. Plasmin was added to a final concentration
of 0.15 Committee of Thrombolytic Agents U/ml (25),
incubation performed at 37°C with magnetic stirring, and the
reaction terminated with soybean trypsin inhibitor (0.2 mg/ml
final concentration).
Gel electrophoresis. Discontinuous polyacrylamide gra-
dient gel electrophoresis in nondissociating conditions
was performed using a modification (14) of previously de-
scribed methods (26, 27). SDS polyacrylamide gel electro-
phoresis was performed using gradient gels as previously
described (22, 27, 28). Molecular weights of reduced poly-
peptide chains were determined by comparison with stand-
ards (-galactosidase (135,000), phosphorylase A (93,000),
bovine serum albumin (68,000), Aa (70,000) and BP3 (58,000)
chains of human fibrinogen, ovalbumin (43,000), carboxy-
peptidase A (34,600), chymotrypsinogen (25,700), soybean
trypsin inhibitor (21,000), and myoglobin (17,000). For non-
reduced proteins, molecular weights were estimated by the
same method, using as standards fibrinogen (340,000), frag-
ment X (250,000), fragment Y (150,000), fragment D (100,000),
bovine serum albumin (68,000), human IgM (900,000), and
fibrin dimer (29) (680,000).
Two-dimensional electrophoresis. For nondissociated
followed by an SDS-nonreducing system, polyacrylamide
gradient gel electrophoresis was performed as above, after
which an electrophoretic track was removed and incubated
at 37°C for 1 h in a solution of 3.75% SDS, 0.025% NaEDTA
and 0.1 Mboric acid-Tris buffer, pH 8.6. The strip was then
incorporated perpendicularly into the stacking gel of an
SDS-polyacrylamide gradient gel and electrophoresed in
Tris-borate-SDS buffer as described above. For SDS non-
reduced followed by an SDS reduced system, the excised
electrophoretic track was incubated at 60°C for 1 h in a solution
of 3.75% SDS, 0.025% NaEDTA, and 0.15 M dithiothreitol
in Tris-borate buffer, pH 8.6, then incorporated perpen-
dicularly into the stacking gel, and electrophoresed as above
in Tris-borate-SDS buffer, pH 8.6, containing 0.01 M dithio-
threitol.
Gel filtration. Plasmic digests of crosslinked fibrin were
chromatographed on a column (158 x 2.7 cm) of Sephacryl
S-300 (Pharmacia Fine Chemicals) using 0.15 M sodium
chloride, 0.05 MTris-buffer, pH 7.6 containing 0.02 Mepsilon
aminocaproic acid and aprotinin (10 kallikrein inactivator U/
ml final concentration) at a rate of 30 ml/h at 25°C. The ab-
sorbance at 280 nm was monitored continuously (UV-2
monitor, Pharmacia Fine Chemicals).
The molecular weights of proteins in the separated peaks
were estimated by comparison with the elution positions of
proteins of known molecular weight. These included IgM
(900,000), thyroglobulin (669,000), ferritin (440,000), catalase
(210,000), aldolase (158,000), human immunoglobulin G
(150,000), bovine albumin dimer (136,000), and bovine
albumin (68,000). Linear regression analysis was used to cal-
culate the best straight line equation for the points describing
elution position and the logarithm of molecular weight.
Sedimentation velocity and equilibrium analysis. The
sedimentation studies were carried out with the Spinco model
E analytical ultracentrifuge (Beckman Instruments, Inc.,
Spinco Div., Palo Alto, Calif.) equipped with a split beam
photoelectric scanning system. The velocity runs were made
at 44,000 rpm at or near room temperature in a 12-mm
double sector cell. Corrected sedimentation coefficients,
S20.W, were calculated by standard methods (30). The equilib-
rium runs were made using a multichannel equilibrium
centerpiece at 6,000 and 6,800 rpm at or near 15°C using
the technique to prevent convection as described by Schach-
man and Edelstein (31). All scans were made at 280 nm.
The molecular weights were calculated from the equi-
librium data by the equation:
2RT dlnc
mol wt =
(1 - Vp)W2 dr2
where c is directly proportional to the recorder deflections
of the scanner at 280 nm.
RESULTS
Crosslinked fibrin was exposed to plasmin and the
solubilized protein present at different intervals of
digestion examined electrophorectically.1 Electro-
1 The polypeptide chains of fibrinogen and fibrin are named
according to the nomenclature suggested by the International
Society of Thrombosis and Haemostasis (32). Those of fibrino-
gen are called Aa, B(3, and y; those of noncrosslinked fibrin
a, 83 and y; and those of crosslinked fibrin a polymers (ap),
,8, and y dimers (yy). Fragments of a polypeptide chain re-
sulting from cleavage at the amino terminal end are indicated
by a / preceding the symbol of the parent chain, and fragments
resulting from cleavage at the carboxy terminal end are indi-
cated by a / following the symbol. Stages of degradation of
plasmic lysates of crosslinked fibrin are defined in this report
according to Francis et al. (22), based on the SDS-poly-
acrylamide gel electrophoretic pattern of reduced protein, as
shown in Fig. 1C. Stage 1 digests have predominantly intact yy
chains. Stage 2 digests have a heterogeneous mixture of yy
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FIGURE 1 Electrophoresis of plasmic digests of crosslinked fibrin in three different poly-
acrylamide gel systems. In this experiment the stage 1, 2, and 3 digests were exposed to plasmin
for 1, 4, and 12 h, respectively. The arrows indicate the demarcation between stacking gel (above)
and separating gel (below). The nondissociating, discontinuous buffer system (left) utilized a
4-10% linear gradient separating gel and a 4%stacking gel. The amount of protein applied was
30 ,Ag in 10 A.l of buffer for each sample. Electrophoresis in SDS-containing buffer (center)
utilized a 4-10% linear gradient separating gel with a 4% stacking gel. Amounts of protein
applied were 7, 9, and 10 ,ug for the stage 1, 2, and 3 digests, respectively. Disulfide bond reduced
protein was electrophoresed in SDS in a 5-14% linear gradient gel with a 5% stacking gel
(right). Volumes of 20 ul containing 7, 17, and 26 Zg of the stage 1, 2, and 3 samples, respectively,
were applied. The crosslinked fibrin used as substrate for these digestions is shown to the far
right, and demonstrates yy chains of 100,000 and 108,000 mol wt (34). The bands corresponding to
partially degraded forms of the smaller yy chain seen in the stage 1 and stage 2 digests are of
95,000, 90,000 and 86,000 mol wt. The terminal yy derivatives seen in the stage 3 digest are
of 79,000 and 87,000 mol wt.
phoresis in nondissociating conditions identified at
least four distinct protein stained bands, labeled bands
1-4 in order of decreasing electrophoretic mobility;
some protein failed to enter the 4%stacking gel (Fig. 1A).
With longer times of exposure to plasmin, the digest
showed progressive loss of bands 2-4 and of the
protein that stayed at the top of the gel, while there
was accumulation of protein migrating as band 1. The
terminal digest consisted almost entirely of band 1,
and showed no change in electrophoretic pattern even
after an additional 24 h of exposure to enzyme.
Electrophoresis in the presence of SDS disrupted
noncovalent bonds holding the complexes together
and demonstrated the covalently bound fragments
contained in the digests (Fig. 1B). At least 10 prominent
bands with molecular weights between 195,000 and
595,000 and some protein that failed to enter the
stacking gel (molecular weight greater than one million)
were present in the initial lysate (stage 1). Continued
exposure to plasmin resulted in loss of the higher molec-
ular weight bands and increased prominence of the
195,000 molecular weight band, which represented the
major derivative in the stage 3 digest. Faintly staining
bands with molecular weights of 150,000, 100,000,
85,000, and 45-55,000 were also present in each
digest.
The same digests and the crosslinked fibrin starting
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chains of molecular size ranging from that of the intact form
to that of the smallest remnant. Stage 3 digests have only the
smallest yy remnants. Fragments X, Y, D, and E are defined
according to Marder and Budzynski (33).
A Nondissociated B SDS Nonreduced
material were electrophoresed in the presence of
SDS after disulfide bond reduction (Fig. IC). Cross-
linked fibrin showed complete y chain crosslinking,
extensive ap formation, and residual partially degraded
a! chains. The ap chains were seen faintly at the top of
the stacking gel and were degraded quickly to small
peptides (not seen in these gels). The stage 1 digest
contained both intact yy chains and large /yy derivatives
of 95,000 and 90,000 molecular weight. Progressive
degradation produced derivatives varying from the
intact yy chain to the smallest /yy remnant of 79,000.
The terminal stage 3 pattern showed only the two
smallest /Iy remnants and all S chains cleaved to the /,8
remnant of 43,000 mol wt. Exactly the same sequence
of degradation was obtained in the presence of 5 mM
calcium chloride.
Two-dimensional electrophoresis with nondissoci-
ating conditions in the first dimension and SDS in the
second dimension was used to separate and charac-
terize the components of the noncovalently bound
derivatives present in the digest supernates (Fig. 2).
The 6-h (stage 2) digest supemate separated into three
distinct bands under nondissociating conditions (Fig.
2, left), the most anodal band of which (band 1)
dissociated after electrophoresis in SDS into two
component parts of 195,000 and 45,000-55,000 mol wt.
Band 2 dissociated in the second dimension with SDS
into two major spots corresponding to the bands of
1 st Dimension
nondissociatingi
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FIGURE 2 Two-dimensional gel electrophoresis of plasmic digests of crosslinked fibrin. Initial
separation in a nondissociating buffer using a 3-12% polyacrylamide gradient gel is shown at
the top of both panels; migration in the second dimension proceeded in the presence of an SDS-
containing buffer in a 3-15% polyacrylamide gel. A 50-jsg sample of a 6-h digest was applied in
the first panel and a l1-fig sample of the 1-h digest was applied in the second panel. The vertical
electrophoresis of the samples labeled "fibrin digest" represents single dimension electrophoresis
of the starting material in the SDS-containing buffer.
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195,000 and 247,000 (Fig. 1B). More information on the
content of these bands after migration in SDSbuffer is
available in Fig. 2, right, which shows the results with a
1-h (stage 1) digest. This sample had a greater
proportion of bands 2 and 3 and their component parts
were more readily visible after dissociation by SDS. In
addition to the 195,000 and 247,000 components, band
2 had small amounts of the 45-55,000 moieties. Band 3
resolved into several components, namely those
present in bands 1 and 2, plus higher molecular weight
bands of 285,000, 334,000, 365,000, and 391,000 (Fig.
1B). If present, bands of 45-55,000 were too faint to be
visible in the band 3 pattern. The remaining bands seen
in the first dimension were poorly delineated, and their
component parts in the second dimension could not be
precisely determined. However, only small amounts of
the 195,000 and 247,000 components were present,
with relatively larger amounts of the higher molecular
weight components, including definite contributions of
derivatives with mol wt > 400,000. SDS-polyacrylamide
gel electrophoresis of the chromatographically separated
complexes confirmed the results of the two-dimensional
electrophoresis.
Two-dimensional electrophoresis using an SDS-
containing buffer in the first dimension and disulfide
bond reduction in the second dimension determined
the polypeptide chain composition of component frag-
ments (Fig. 3). After reduction the 195,000 band
showed at least four yy bands, with molecular weights
from 79,000 to 95,000 and a /1( band of 43,000; no intact
,B chains were present. The band corresponding to mol
wt 247,000 also showed heterogeneity of 'yy chain com-
position, but had none of the 79,000 moiety and rela-
tively more of the 90,000 and 95,000 moieties. Most
of the ( chain component was degraded to the 43,000
remnant, but intact (8 chain was also present. The
285,000 band had even less of the smaller /yy deriva-
tives and a greater proportion of the largest remnant
of 95,000; equal proportions of intact (8 and /,B chain
remnant were present. This trend of increasing molec-
ular size of the /yy remnant and increasing proportions
of intact (3 chain noted in the 195,000, 247,000, and
285,000 bands did not hold for the next larger band
of 334,000, which had the same relative polypeptide
chain composition as the 247,000 fragment (Table I).
The chains of the 365,000 fragment resembled those of
the 334,000 fragment, except for the additional pres-
ence of intact 'yy chains. Just as was noted in the com-
parison of 247,000 and 285,000 bands, there was a
change toward larger polypeptide chains between the
patterns of the 334,000 and 391,000 bands. The 391,000
fragment had only the intact y dimer and the largest
/yy remnant of 95,000, without the smaller /yy remnants
and relatively equal proportions of intact (8 and 1,8
chains. The polypeptide chain components of higher
molecular weight fragments were less well resolved
-1st Dimension (SDS, nonreduced) --o. +
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FIGURE 3 Two-dimensional electrophoresis of the 2-h
plasmic digest of crosslinked fibrin. Electrophoresis of the
30-.tg sample in the first dimension (top gel) was performed
in SDS-containing buffer in a 4-10% polyacrylamide gel,
second dimension in reducing buffer in a 5-20% poly-
acrylamide gradient gel. The sample labeled "fibrin digest"
at the right side of the vertical portion represents electro-
phoresis of the disulfide-reduced starting material in the
second dimension only.
in the gel patterns but appeared to have components
similar to those of the 285,000 and 391,000 molecular
weight fragments, with predominantly intact yy and the
largest of the /yy chain remnants, none of the smallest
/yy remnants, and approximately equal proportions of
intact (3 and /,8 chains.
Gel filtration chromatography on Sephacryl S-300
separated the stage 1 digest of crosslinked fibrin into
four protein peaks (Fig. 4), each of which contained
one of the corresponding four bands identified by
electrophoresis in nondissociating conditions (Fig. 1C).
A standard curve correlating elution position with the
molecular weight of standard proteins was used to
estimate the molecular weights of protein eluting in
the four peaks (Table II). Separated protein peaks
representing bands 1-4 were immediately subjected
to analytical ultracentrifugation without prior concen-
tration or dialysis. The molecular weight plots of this
data showed linearity from the top to the bottom of the
cell for all samples, indicating that they were homo-
geneous. The sedimentation coefficients and sedi-
mentation equilibrium molecular weight measure-
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TABLE I
(ualitative Analysis of Component Parts, after Twco-dimensional
Electrophoretic Separationis of Fibrin Digests*
A Nondissociated/SDS-dissociated (Fig. 2)
Fragment
Band 45-55 195 247 285 334 .365 391 461
mnolcular tcuight x 10-3
1 3+ 4+ 0 0 0 0 0 0
2 1+ 2+ 3+ 0 0 0 0 0
3 + 1+ 1+ + 1+ 1+ -4-
B SDS-dissociated/disulfide bond reduced (Fig. 3)
Ponlypeptide chain
13
Fragment Intact yy /yy remnant Intact 6 remnant
n1ol it-t
100,000 95,000 90,000 86,000 79,000 58,000 43,000
195,000 0 1+ 2+ 4+ 3+ 0 4+
247,000 0 2+ 2+ 2+ 0 1 + 3+
285,000 2+ 2+ + 0 0 2+ 2+
334,000 0 2+ 2+ 1 + 0 1 + 3+
365,000 1+ 1+ 1+ 1+ 0 1+ 2+
391,000 1+ 1+ + + 0 1+ 1+
* Primary data for part A shown in Fig. 2, that for part B in Fig. 3; interpretation
based upon arbitrary designations of 0 (absent) to 4+ (heavy band) for the Coo-
massie blue-stained gel patterns. Second dimension components of band 4 (Fig. 2)
or of fragments of 461,000 mol wt or greater (Fig. 3) were not sufficiently de-
lineated to allow such analysis.
ments were compared with those estimated by gel
exclusion calculations in Table II.
DISCUSSION
Wehave shown previously (14) that the soluble com-
plexes released from digesting fibrin always resemble
the stage 1 digest, regardless of the exposure time of
fibrin to plasmin, and that further degradation occurs
primarily in solution after liberation of complexes from
the clot. Whereas such degradation to terminal digests
occurs in vitro where the solubilized protein is con-
tinually exposed to enzyme, it may not occur in vivo
where proteolytic inhibitors are present.
In this study we have purified by gel filtration the
early complexes released from degrading crosslinked
fibrin. Each complex dissociated into two or more
covalently bound fragments that could be separated
by SDS-polyacrylamide gel electrophoresis (Fig. 2).
The smallest complex of 228,000 mol wt was DD/E
(35), but the majority of protein in the stage 1 digest
consisted of the previously uncharacterized larger
complexes. To understand the structure of the non-
covalently bound complexes, we first identified and
characterized their covalently bound subunits. After
this, we were able to develop a model to show the
association of the subunit fragments in complexes and
to explain their derivation from the fibrin matrix.
SDS-polyacrylamide gel electrophoresis of unfrac-
tionated digests of crosslinked fibrin (Fig. 1B) demon-
strates fragment DD(molecular weight 195,000), which
is present in all digests but predominates in the stage
3 digest, fragment Y (150,000), two forms of fragment
D (85,000 and 100,000), and several forms of fragment
E (45,000 to 55,000). These fragments have been well
characterized, but those of higher molecular weight
have not. Alkjaersig et al. (11) found a similar electro-
phoretic pattern, but they did not determine molecular
weights of the individual fragments. Reganon et al.
(12) separated plasmic digests of crosslinked fibrin by
gel filtration in the presence of SDS and noted two
fragments larger than DD, identified as YD with a
molecular weight of 220,000 and YY with a molecular
weight of 270,000, by analysis of their reduced poly-
peptide chain composition.
We have deduced the structure of five fragments























FIGURE 4 Sephacryl S-300 gel elution of a stage 1 digest of
crosslinked fibrin. Horizontal axis indicates the cumulative
elution volume and the vertical axis indicates optical density,
normalized for the maximumof 0.44. The void volume was 285
ml as determined by elution of dextran blue. Gel electro-
phoresis of starting material and the protein in each peak
under nondissociating conditions shows bands correspond-
ing to those in Fig. 1A. Band 4 is quite faint, and protein
in peak 4 was difficult to resolve with this electrophoretic
system, some remaining at the top of the stacking gel and
some entering only a short distance.
larger than DD by determination of their molecular
weights (Fig. 1) and polypeptide chain composition
(Fig. 3) and by predictions based on known sites of
plasmic cleavage of fibrin. Fig. 5 shows diagrammatically
the covalently bound derivatives which would result
from cleavages at known sites of plasmin action on
fibrin (33, 38-44), especially those between the D and
E domains and at or near the yy crosslink site. Takagi
and Doolittle (45) have identified a plasmin-sensitive
site at lysine (405)-glutamine (406) of the y chain that
is compatible with the latter, and Olexa et al. (46)
and Purves et al. (47) have shown plasmic cleavages
near the yy crosslink. The number and molecular
weights of fragments predicted were in strong agree-
ment with those identified in digests of crosslinked
TABLE II
Molecular WVeight of Nondissocia ted Complexes
in Crosslinked Fibrin Digests*
Ultracentrifuge
Complex Gel filtration S,20-,, Equilibrium sedimentation
1 290,000 7.1 228,000
2 543,000 12.3 465,000
3 747,000 16.0 703,000
4 880,000 19.9 850,000
* Complexes named according to the elution peaks from Seph-
acrvl S-300 column (Fig. 4) each of which corresponds to bands
1-4 noted in Figs. IA, 2, and 4.
fibrin (Fig. 1B). In addition, their polypeptide chain
composition demonstrated by two-dimensional electro-
phoresis (Fig. 3, Table I) was consistent with that
predicted from the schematic diagram.
The molecular weights predicted for fragment X or
DY were very close, and both were compatible with
the band of 247,000 mol wt (Fig. 1B). The polypeptide
chain composition of this fragment identified by two-
dimensional electrophoresis (Fig. 3, Table I) was com-
patible only with fragment DY, since crosslinked y
chain derivatives would not exist within the structure
of fragment X (42, 43, 46). Since one D to E domain
connection remains uncleaved in DY, intact ( chains as
well as 1,8 chains should have been present and larger
/Iy chains should have predominated; these results
were demonstrated in Fig. 3. A fragment correspond-
ing to that of fragment X could not be identified with
certainty in the SDS gel electrophoretic patterns,
although the occasional splitting of the 247,000 band
(Fig. 2, left) may represent both the DYand X fragments.
The structure of fragment YY predicts that it should
contain intact yy and (8 chains and this was confirmed
by two-dimensional electrophoresis (Fig. 3, Table I).
The presence of a 1,8 band is explained by the usual
occurrence of f8 chain cleavage before -y chain cleavage
(44), which would result in some molecules containing
cleaved f8 but intact y-y chains. The formation of frag-
ments XD and XY would require a cleavage near an
isopeptide yy crosslink (Fig. 5). Three bands of 391,000,
365,000, and 334,000 mol wt were distinguishable
in Fig. 1B, all of which are compatible with only the
XY and XD moieties. That these derivatives were
identified suggests that the protection from plasmic
degradation that is ascribed to -y chain crosslinking (42)
may not be complete.
The polypeptide chain composition of higher
molecular weight fragments was less well resolved
by two-dimensional electrophoresis, but there was
excellent agreement between the number of deriva-
tives, their molecular weights predicted from Fig. 5,





f - XD (346-359) -





F- DY (242-256) -
I - VYY (292-310) lI
DXD (442-470) -
i YXD (492-514)
i YXY (542-568) -
FIGURE 5 Schematic diagram of plasmic cleavage sites of a single strand of crosslinked fibrin
and the deduced degradation fragments liberated into solution. The fragments noted here would
consist of nonreduced, covalently bound protein and correspond to bands identifiable by electro-
phoresis in SDS-containing buffers, such as seen in Figs. 1B, 2, and 3. The fibrin monomers are
joined by covalent isopeptide crosslinks between antiparallel y chains (double vertical lines
(36). Crosslinks between a chains are not shown because a polymer chains are cleaved by plasmin
before there is significant proteolysis of f8 or y chains (37). The heavy vertical arrows indicate
cleavages of ychains at or near the yy cross-link. Disulfide bond regions are indicated schematically
by the square located at the center of each fibrin molecule (E domain) and by the single vertical
lines joining the lateral extensions of a, (3, and y chains (D domains). Cleavage sites between Dand E
domains are indicated by the thin arrows above and below the fibrin chain. Derivatives that result
from cleavages only at these sites and contain an intact yy crosslink are shown in the lower part
of the figure ("intact crosslink"). Derivatives that result from both D/E domain cleavages and
from cleavages near the yy isopeptide bonds are shown in the upper portion ("cleaved crosslink").
The predicted molecular weight range for each species is noted in parentheses, determined by
summation of the molecular weights of constituent, a, f3, and y chain remnants resulting from
cleavages at the indicated sites.
and those identified by SDS-polyacrylamide gel
electrophoresis (Fig. 1B and Fig. 2, left). Thus, fragments
of molecular weight 461,000, 500,000, 542,000, and
595,000 correspond to the molecular weights predicted
for fragments DXD, YXD or XX, YXY, and XXD, re-
spectively.
The structure of noncovalently bound complexes
was deduced by their molecular weights (Table II)
and component fragments (Table I). Protein migrating
as band 1 dissociated in SDS(Fig. 2) into components
of 195,000 (DD) and 45-55,000 (E), confirming its
identity as DD/E (9, 10). Complex 2 had a molecular
weight approximately double that of DD/E (Table II)
and dissociated into fragments DY, DD, and E (Fig. 2).
The proposed structure of complex 2 is shown in Fig. 6,
in which fibrin is represented as a two-stranded,
half-staggered overlap fiber, with noncovalent attrac-
tions between D and E domains of adjacent fibrin
strands (48,49). Whereas complex 1 would derive from
fragment DDof one fibrin strand and fragment E from
the adjacent strand, joined by noncovalent attraction,
complex 2 would consist of two antiparallel DY frag-
ments, held together by the same noncovalent bond
between adjacent DDand E regions. The structure of
complex 2 is compatible with the measured molecular
weight, since it is double that of complex 1 and within
6% of the sum of two component YD fragments of
247,000 each (Fig. 2). Cleavage between the D and E









Complex 1 Complex 2 Complex 3
FIGURE 6 Structure and it situ derivation of complexes 1, 2, and 3 derived from plasmic degrada-
tion of crosslinked fibrin. Two linear fibrin polymers are shown in a half-staggered overlap array
w..ith covalent crosslinks betveen y chains indicated as double lines between adjacent D domains.
The crosslinks between a chains are not shown. Complex 1 shows D dimer (DD) apposed to frag-
ment E of the other fibrin strand. The nomenclature of the covalently-bound fragments con-
tributed by each fibrin strand to complexes 2 and 3 corresponds to that indicated in Fig. 5. The
complexes could therefore be expressed as DD/E (complex 1), DY/YD (complex 2), and DXD/YY
(complex 3). All complexes that are larger than complex 1 have considerable heterogeneity
resulting from proteolytic cleavages that do not disrupt the noncovalent bonds holding the
fragments of the two chains together as a complex.
domains of one fibrin strand of complex 2 would result
in potential DD and E fragments, as seen in Fig. 2,
but would not disrupt its noncovalently bound struc-
ture. Plasmic cleavages between DDand E domains
in both adjacent fibrin polymer strands would result
in two complex 1 units.
The molecular weight of complex 3 was only 3%
greater than three times that of complex 1. Two-dimen-
sional electrophoresis (Fig. 2B, Table I) showed that it
contained covalently bound fragments as large as DXD
(461,000) and YY (285,000). Its molecular weight
measured by equilibrium sedimentation (703,000) was
within 6%of the sum (746,000) of its intact constituent
subunits, DXDand YY. Cleavages between D and E
domains within the complex could produce fragments
DY and DD observed in Fig. 2, without necessarily
disrupting its noncovalently bound integrity.
The components of complex 4 were not well re-
solved by two-dimensional electrophoresis and its
structure was less well determined. The logical exten-
sion of the scheme in Fig. 6 would suggest an alignment
of antiparallel, noncovalently bound fragments YXD
and DXY. The molecular weight of such a complex
should be four times that of complex 1 (912,000) or
equal to the sum of its component fragments (1,000,000).
The observed molecular weight of 850,000 was 7%
and 15% less than the respective predicted maximal
sizes. This suggests that complex 4 was an unstable
derivative or that it was seldom released from fibrin
in its intact form.
Our scheme of complexes is the only series of two-
stranded noncovalently bound derivatives that could
result from plasmin cleavages between complementary
D and E domains. Furthermore, variations on the
proposed basic structure of the complexes can be
logically drawn to explain the multitude of component
fragments that dissociate in SDS from the complexes
(Fig. 2). For instance, an adjacent D or E domain may
be attached to the complex as the result of cleavage
just outside the usual boundary of the complex. Ex-
amples of such variants were DY in complex 1, YY in
complex 2, and DXY in complex 3.
Internal cleavages between D and E domains were
probably frequent, as indicated by the large amounts
of DD in complex 2 and of DYand DDin complex 3.
Variations resulting from cleavages at or near a yy
isopeptide bond occurred less often but resulted in D
and Y in complex 1 and in Y, D, and XD in complex 2.
Relatively large amounts of fragments X, Y and XD
were present in complex 3 (Fig. 2), indicating that
the yy cleavage site may be more accessible within
the intact fibrin strand than in liberated complexes.
Our results are in conflict with those of Gaffney
and Joe (13) who suggest that digestion of crosslinked
fibrin by plasmin does not yield a variety of high
molecular weight fragments, but only DD/E which may
then aggregate to form larger complexes. Although our
data do not rule out complex aggregation subsequent
to release into solution, the structure of component
covalent fragments making up the complexes are not
compatible with their derivation by noncovalent
aggregation of DD/E complexes. Our results support
the conclusions of Reganon et al. (12) that DY and YY
are the next larger covalent fragments after DD, al-
though our measured molecular weights differ.
The data presented supports the two-stranded half-
staggered overlap model (15) as the basic structure of
crosslinked fibrin. The principal cleavage site for cross-
linked fibrin is apparently the same as for fibrinogen,
namely in the "coiled coil" region connecting the
central and terminal domains (50). The complexes
larger than DD/E probably have considerable physio-
Plasmic Degradation of Crosslinked Fibrin 1041
(DD) (DXD)
logic relevance, inasmuch as they always comprise
the bulk of newly released protein from fibrin clots
undergoing plasmic degradation in vitro (14).
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